Study of treatments and outcomes for primary skin lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at what treatments work for people with primary cutaneous lymphoma, and how patients do over time. It uses real patient information from participating hospitals to understand outcomes after diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were evaluated at a participating medical center in the study
- Your skin biopsy confirmed primary cutaneous lymphoma (a pathologist diagnosis)
- You can provide informed consent (agree to take part)
- You can complete the study questionnaires on your own, or with help from the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why skin lymphomas behave differently from person to person and may identify new targets for treatment. You may be invited if you have (or are being evaluated for) a suspected or confirmed skin lymphoma.
This study follows people with primary cutaneous T-cell lymphoma who are seen at the Dermatology Unit in Pavia. It collects information to better understand the disease and improve care.
This study reviews medical records of patients treated for cutaneous T-cell lymphoma (a type of blood cancer affecting the skin) at Hospital México in Costa Rica. Researchers will examine how the disease is diagnosed, staged, and treated to better understand patterns and outcomes.
This study aims to understand how common skin lymphomas are in Italy. You might be able to help if you have been diagnosed with a skin lymphoma.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
This study asks people with cutaneous lymphoma to fill out a questionnaire about quality of life. The goal is to better understand how this illness affects day-to-day life and comfort.
Hear when a new Primary Cutaneous Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.